Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ypsomed Holding AG buy melinda

Start price
€176.65
05.07.17 / 50%
Target price
€200.00
27.12.17
Performance (%)
-22.85%
End price
€136.28
27.12.17
Summary
This prediction ended on 27.12.17 with a price of €136.28. The prediction for Ypsomed Holding AG disappointed with a performance of -22.85%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Ypsomed Holding AG - - - -
iShares Core DAX® 4.094% 4.888% 17.421% 22.413%
iShares Nasdaq 100 1.424% -0.445% 37.618% 58.203%
iShares Nikkei 225® -1.572% -4.911% 12.951% 7.961%
iShares S&P 500 1.822% 0.776% 29.182% 49.914%

Comments by melinda for this prediction

In the thread Ypsomed Holding AG diskutieren
Prediction Buy
Perf. (%) -22.85%
Target price 200.000
Change
Ends at 27.12.17

Insulin-Pens hat



Der Bericht schließt mit Profilen der wichtigsten Akteure in der Insulin - Pens Markt wie Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. Die wichtigsten Marktteilnehmer werden auf verschiedenen Parametern wie Unternehmens - Übersicht, Perspektiven des Produkts und die neuesten Entwicklungen und Trends im Insulinpen Markt bewertet.


Prediction Buy
Perf. (%) -22.85%
Target price 200.000
Change
Ends at 27.12.17

(Vom Mitglied beendet)

Stopped prediction by melinda for Ypsomed Holding AG

buy
Ypsomed Holding AG

Start price
Target price
Perf. (%)
€176.65
05.07.17
€200.00
27.12.17
-22.85%
27.12.17